版本:
中国

BRIEF-Penumbra's voluntary field removal of its 3D revascularization devices will not impact its revenue guidance

June 13 Penumbra Inc-

* On June 9, co initiated a voluntary field removal of four lots of its 3D revascularization devices - SEC filing

* Voluntary field removal was based on company's identification of an issue involving a raw material component of the devices

* Penumbra Inc - does not currently expect that this voluntary action will have material impact on its previously issued revenue guidance - sec filing

* The four lots of its 3d revascularization devices were distributed between May 15, 2017 and June 7, 2017 Source text: (bit.ly/2thb52M) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐